After 24 months, three out of four patients had a moderate response measured using European league against rheumatism (EULAR) parameters, erythrocyte sedimentation rate (ESR), C reactive protein (CRP), disease activity score (DAS) 28, and VAS score (165). The gene discussed is CRP; the disease is rheumatic disorder.